The global pharmaceutical industry relies heavily on a robust supply chain for high-quality chemical intermediates. Among these, (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide (CAS: 521284-19-5) holds a significant position, particularly for its role in the development of diabetes treatments.

For companies looking to buy this essential compound, understanding the advantages of sourcing from China is key. As a prominent manufacturer and supplier in China, we provide (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide, characterized by its Off-White to Pale Yellow Solid appearance, molecular formula C16H16N2O4, and molecular weight of 300.31. Our focus on quality assurance ensures that these intermediates meet stringent industry standards.

The synthesis of this compound requires precise chemical processes, and our expertise in organic synthesis allows us to produce it with high purity. This is crucial for its application as a pharmaceutical intermediate, especially in the creation of (aminothiazolyl)acetanilide derivatives for diabetes therapy. The reliability of the chemical properties, such as its melting point and solubility, is paramount for successful research and development.

Sourcing from China offers several benefits, including competitive pricing and large-scale production capabilities. As a dedicated manufacturer, we can meet diverse order quantities, from laboratory research needs to bulk industrial requirements. The competitive price point makes advanced pharmaceutical research more accessible globally.

The compound's recognition as a Mirabegron intermediate further highlights its market relevance. The demand for intermediates like this remains consistently high due to ongoing research and the need for established pharmaceutical ingredients. Our commitment as a China-based manufacturer is to provide a stable supply chain, ensuring that our clients can procure necessary materials without disruption.

In conclusion, procuring (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide from reputable Chinese manufacturers like us offers a strategic advantage. It combines high-quality production with cost-effectiveness, supporting the critical work of pharmaceutical researchers and developers focused on advancing treatments for conditions such as diabetes.